PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding PDS Biotechnology Corp changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 72 | 77 | +5 |
| Shares | 7.63M | 5.50M | −2.12M (−27.8%) |
| Value | $30.2M | $16.1M | −$14.1M (−46.6%) |
New holders (25)
Institutions that held PDS Biotechnology Corp at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (20)
Institutions that held PDS Biotechnology Corp at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Renaissance Technologies LLC | 354,800 | $1.41M |
| Nuveen Asset Management, LLC | 110,296 | $436.8K |
| Marshall Wace, LLP | 41,221 | $163.2K |
| Alliancebernstein L.P. | 37,840 | $149.8K |
| Wolverine Trading, LLC | 29,602 | $117.2K |
| Rathbone Brothers plc | 15,800 | $62.6K |
| Deutsche Bank AG | 15,408 | $61.0K |
| MetLife Investment Management | 15,026 | $59.5K |
| American International Group, Inc. | 13,952 | $55.3K |
| Manufacturers Life Insurance Company, The | 12,134 | $48.1K |
| Gsa Capital Partners LLP | 10,358 | $41.0K |
| Legal & General Group Plc | 2,988 | $11.8K |
| California State Teachers Retirement System | 2,846 | $11.3K |
| Ameritas Investment Partners, Inc. | 2,309 | $9.14K |
| Truvestments Capital LLC | 1,372 | $5.43K |
| Amalgamated Bank | 943 | $4.00K |
| STRS Ohio | 400 | $1.00K |
| Metropolitan Life Insurance Co | 235 | $931 |
| The PNC Financial Services Group, Inc. | 8 | $32 |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 5 | $19 |